EMJ GOLD

📢 The results are in. How did HCPs consume medical content in 2024? Our new infographic reveals all. Discover here: https://hubs.la/Q037v90_0

Leaders from key pharmaceutical companies operating in the UK are warning that the country’s life sciences growth plan is at risk – unless the government addresses unsustainable payment rates on manufacturers: https://hubs.la/Q03cLf-R0

💊 Pfizer is out of Haleon Pfizer has officially sold its remaining stake in Haleon, marking a full departure from the consumer healthcare business. Discover more: https://hubs.la/Q03cyG0M0

"The true essence of leadership lies in inspiring others to dream audaciously and providing them with the framework to turn those dreams into reality." It's time for another '5 minutes with...' interview and this time we caught up with Prof Alexander Egeberg, LEO Pharma, to talk about unmet needs in dermatology and how to foster a culture of “thinking bigger” at work. Read it now: https://hubs.la/Q03cvV4y0

Yesterday, I swapped my desk for WIRED Health 2025, diving into a day of interesting talks, firesides and debates. From AMR to AI-driven drug discovery, here are some key takeaways: 🦠 AMR isn’t a future problem – it’s happening now. Over 36 million lives have been lost since 1990, and healthcare costs could rise by $150bn a year if no decisive action is taken. But for every $1 invested in AMR, there’s a $24 return. The message? Act now. ⏳ Ageing might not be inevitable. Research on torpor states in mice suggests slowing ageing could be possible. Stressful events accelerate biological ageing, while epigenetic clocks offer ways to track and understand the process. 🤖 AI + genetics = a power couple. We don’t fully understand human biology, but AI can help bridge the gaps and speed up timelines in drug development. Companies need to rethink how they innovate to keep up. 🔬 Microbiome science is evolving fast. As much as 90% of it is influenced by diet and lifestyle, yet misconceptions still linger. The challenge? Cutting through the noise to unlock evidence-backed insights. ⚖️ Rethinking diagnosis. Early detection may not always be the answer – some cancers never progress, and could over-diagnosis do more harm than good? The focus should be on personalised, preventative medicine. 💉 Could vaccines stop cancer coming back? The next generation of mRNA vaccines are on the horizon. These could train the immune system to recognise and fight a patient’s specific cancer, potentially preventing relapse. A fascinating day full of insights enjoyed alongside Evgenia Koutsouki, PhD! #WIREDHealth

How can other therapy areas tap into the success AI has found in radiology? In our latest podcast, Naiara Martínez Cabrera, MBA, DeepHealth, talks to Jade Williams 🎙️about the transformative impact AI is having on radiology—and where it could lead next across the healthcare landscape. Watch now: https://hubs.la/Q03ckHvj0

🚨 New $1bn oncology deal AstraZeneca is set to acquire EsoBiotec, bringing in vivo cell therapies into its pipeline. The technology reprogrammes immune cells inside the body, potentially transforming cancer treatment. Read more: https://hubs.la/Q03c6cVW0

The NICE - National Institute for Health and Care Excellence has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England. Find out more: https://hubs.la/Q03bGQ-W0

"Women’s potential is often overlooked—where a man balancing work and family is praised, a woman can be criticised for doing the same" How can pharma truly accelerate action for gender parity? Find out what three industry experts think in this roundtable interview, featuring Kasha Witkos, Alnylam Pharmaceuticals, Rebecca Guntern, Sandoz and Mar Carrasco Calvo, Bristol Myers Squibb, who share obstacles they have faced in their careers and advice to their younger selves. Read it here: https://hubs.la/Q03bwlks0

The compound, known as DMT, is found in certain plants, but can also be produced synthetically, opening up the possibility of using it therapeutically. Read more: https://hubs.la/Q03blgF00